Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 16, 2025Journal of Posthumanism

Vitamin D supplementation and mortality risk in chronic kidney disease a meta-analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

AAAtef H. AljahdalyKAKhalid AlmalkiHAHIFTHI K.AL ALTHEEB

Discussion

Loading...

Member takes

Overview

Meta-analysis uncovers associations between vitamin D supplementation and mortality risk in CKD patients, suggesting its therapeutic role.

Key Points

  • Vitamin D supplementation significantly reduces mortality risk in chronic kidney disease patients.
  • In the meta-analysis, an odds ratio of 0.54 indicates a strong correlation to reduced mortality.
  • Eight studies with 57,429 patients were reviewed, assessing both biochemical parameters and mortality outcomes.
  • Findings highlight the therapeutic potential of vitamin D in improving survival and managing parathyroid hormone levels.

Cite This Study

Aljahdaly et al. (2024) studied this question.

synapsesocial.com/papers/68d441a6713b0b5dfea80b4chttps://doi.org/10.63332/joph.v4i3.3325
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Role of Vitamin D Deficiency in the Progression of Chronic Kidney Disease: Implications for Early Intervention and Management2025
  2. 2The Role of Vitamin K Deficiency in Chronic Kidney Disease—Cause or Consequence?2025 · 1 citations
  3. 3The Role of Vitamin K Deficiency in Chronic Kidney Disease—A Scoping Review2025 · 2 citations
  4. 4Major adverse kidney events among chronic kidney disease patients with vitamin D deficiency2025 · 4 citations
  5. 5Age-specific benefits of Vitamin D and its association with mortality2025